The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(1-(4-chlorobenzyl)-1H-indole-2-carbonyl)-N-(2-(pyridin-4-yl)ethyl)-2-azaspiro[3.3]heptane-6-carboxamide ID: ALA4862885
PubChem CID: 164623643
Max Phase: Preclinical
Molecular Formula: C30H29ClN4O2
Molecular Weight: 513.04
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCCc1ccncc1)C1CC2(C1)CN(C(=O)c1cc3ccccc3n1Cc1ccc(Cl)cc1)C2
Standard InChI: InChI=1S/C30H29ClN4O2/c31-25-7-5-22(6-8-25)18-35-26-4-2-1-3-23(26)15-27(35)29(37)34-19-30(20-34)16-24(17-30)28(36)33-14-11-21-9-12-32-13-10-21/h1-10,12-13,15,24H,11,14,16-20H2,(H,33,36)
Standard InChI Key: BFYYDFMSHICHFA-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 42 0 0 0 0 0 0 0 0999 V2000
20.3166 -13.4323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3124 -12.6070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4871 -12.6111 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4913 -13.4365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1851 -14.2144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7995 -14.7681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6287 -15.5755 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5846 -14.5145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1989 -15.0640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9840 -14.8103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5942 -15.3640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4196 -16.1686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0330 -16.7179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8192 -16.4644 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9883 -15.6523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3735 -15.1066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1440 -13.3926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3628 -14.2638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2726 -9.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2714 -10.6025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9870 -11.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7043 -10.6020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7015 -9.7712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9852 -9.3640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4202 -11.0156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4214 -11.8409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8376 -13.1064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0901 -12.3209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0123 -13.1077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7596 -12.3261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9573 -12.1574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4070 -12.7697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6686 -13.5531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4703 -13.7179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5572 -9.3644 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.8741 -12.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0461 -11.2563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 1 1 0
5 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 1 0
17 1 1 0
1 18 1 0
18 5 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 26 1 0
26 30 1 0
29 27 1 0
27 28 2 0
28 26 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
19 35 1 0
28 36 1 0
36 37 2 0
36 3 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 513.04Molecular Weight (Monoisotopic): 512.1979AlogP: 4.95#Rotatable Bonds: 7Polar Surface Area: 67.23Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 5.05CX LogP: 4.12CX LogD: 4.12Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.38Np Likeness Score: -1.15
References 1. Barraza SJ, Sindac JA, Dobry CJ, Delekta PC, Lee PH, Miller DJ, Larsen SD.. (2021) Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore., 46 [PMID:34098081 ] [10.1016/j.bmcl.2021.128171 ]